208 related articles for article (PubMed ID: 31574294)
1. "NRF2 addiction" in lung cancer cells and its impact on cancer therapy.
Hammad A; Namani A; Elshaer M; Wang XJ; Tang X
Cancer Lett; 2019 Dec; 467():40-49. PubMed ID: 31574294
[TBL] [Abstract][Full Text] [Related]
2. NRF2 and the Hallmarks of Cancer.
Rojo de la Vega M; Chapman E; Zhang DD
Cancer Cell; 2018 Jul; 34(1):21-43. PubMed ID: 29731393
[TBL] [Abstract][Full Text] [Related]
3. NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism.
Fox DB; Garcia NMG; McKinney BJ; Lupo R; Noteware LC; Newcomb R; Liu J; Locasale JW; Hirschey MD; Alvarez JV
Nat Metab; 2020 Apr; 2(4):318-334. PubMed ID: 32691018
[TBL] [Abstract][Full Text] [Related]
4. [Research Progress of Nrf2 and Ferroptosis in Tumor Drug Resistance].
Hu S; Zou X; Fang Y; Liu C; Chen R; Ji L
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):765-773. PubMed ID: 37989339
[TBL] [Abstract][Full Text] [Related]
5. Modulating NRF2 in Disease: Timing Is Everything.
Dodson M; de la Vega MR; Cholanians AB; Schmidlin CJ; Chapman E; Zhang DD
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():555-575. PubMed ID: 30256716
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 in Cancer, Detoxifying Enzymes and Cell Death Programs.
Jenkins T; Gouge J
Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34202320
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of LNC EBLN3P Enhances Radiation-Induced Mitochondrial Damage in Lung Cancer Cells by Targeting the Keap1/Nrf2/HO-1 Axis.
Tang H; Liu S; Yan X; Jin Y; He X; Huang H; Liu L; Hu W; Wu A
Biology (Basel); 2023 Sep; 12(9):. PubMed ID: 37759607
[TBL] [Abstract][Full Text] [Related]
8. Nrf2, A Target for Precision Oncology in Cancer Prognosis and Treatment.
Ngo HKC; Le H; Surh YJ
J Cancer Prev; 2023 Dec; 28(4):131-142. PubMed ID: 38205365
[TBL] [Abstract][Full Text] [Related]
9. "Keaping" an Eye on the NRF2 Signature Score: Expanding Its Applicability in Lung Cancer.
Niu Y; Yao F; Yang H
J Thorac Oncol; 2023 Nov; 18(11):e126-e128. PubMed ID: 37879768
[No Abstract] [Full Text] [Related]
10. Exploring structural effects in a new class of NRF2 inhibitors.
Hou Z; Lockwood L; Zhang D; Occhiuto CJ; Mo L; Aldrich KE; Stoub HE; Gallo KA; Liby KT; Odom AL
RSC Med Chem; 2023 Jan; 14(1):74-84. PubMed ID: 36760735
[TBL] [Abstract][Full Text] [Related]
11. The Involvement of Peroxiporins and Antioxidant Transcription Factors in Breast Cancer Therapy Resistance.
Milković L; Mlinarić M; Lučić I; Čipak Gašparović A
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136293
[TBL] [Abstract][Full Text] [Related]
12. Sex-specificity in lung cancer risk.
Stapelfeld C; Dammann C; Maser E
Int J Cancer; 2020 May; 146(9):2376-2382. PubMed ID: 31583690
[TBL] [Abstract][Full Text] [Related]
13. Clinical lipidomics in understanding of lung cancer: Opportunity and challenge.
Zhang L; Zhu B; Zeng Y; Shen H; Zhang J; Wang X
Cancer Lett; 2020 Feb; 470():75-83. PubMed ID: 31655086
[TBL] [Abstract][Full Text] [Related]
14. Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy.
Lim ZF; Ma PC
J Hematol Oncol; 2019 Dec; 12(1):134. PubMed ID: 31815659
[TBL] [Abstract][Full Text] [Related]
15. Understanding Lung Cancer Treatment Advances.
Oncology (Williston Park); 2019 Dec; 33(12):. PubMed ID: 31914203
[No Abstract] [Full Text] [Related]
16. Epidemiology of lung cancer and lung cancer screening programs in China and the United States.
Yang D; Liu Y; Bai C; Wang X; Powell CA
Cancer Lett; 2020 Jan; 468():82-87. PubMed ID: 31600530
[TBL] [Abstract][Full Text] [Related]
17. The Role of Nrf2 Activity in Cancer Development and Progression.
Zimta AA; Cenariu D; Irimie A; Magdo L; Nabavi SM; Atanasov AG; Berindan-Neagoe I
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31717324
[TBL] [Abstract][Full Text] [Related]
18. Lung Cancer 2020: Epidemiology, Etiology, and Prevention.
Bade BC; Dela Cruz CS
Clin Chest Med; 2020 Mar; 41(1):1-24. PubMed ID: 32008623
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer: some progress, but still a lot more to do.
The Lancet
Lancet; 2019 Nov; 394(10212):1880. PubMed ID: 31777378
[No Abstract] [Full Text] [Related]
20. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways.
Namani A; Liu K; Wang S; Zhou X; Liao Y; Wang H; Wang XJ; Tang X
Aging (Albany NY); 2019 Dec; 11(24):12600-12623. PubMed ID: 31884422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
